a diverse autism registry for etiologic and effectiveness studies prevalance and demographic...
DESCRIPTION
Mental HealthTRANSCRIPT
![Page 1: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/1.jpg)
A Diverse Autism Registry for Etiologic and Effectiveness Studies: Prevalence and
Demographic Characteristics
![Page 2: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/2.jpg)
Background
• Prevalence of Autism Spectrum Disorders (ASD) is rising
• Current estimate: 1 in 88 children• Little is known about causes• Very limited evidence-base on treatments• Locating, characterizing, and enrolling sufficiently
large and representative ASD patient samples is a major limitation
![Page 3: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/3.jpg)
Objective
• Create a large, comprehensive, and dynamic ASD registry to enable rapid identification and enrollment of patients into large-scale studies investigating treatment interventions as well as pharmacogenomic and etiologic hypotheses
![Page 4: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/4.jpg)
Participating MHRN sites
• KPNC - Division of Research• KPSC - Dept. of Research and Evaluation• KPNW - Center for Health Research• KPGA - Center for Health Research,
Southeast• Harvard Pilgrim Health Care
![Page 5: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/5.jpg)
Specific Aims1. Refine and validate case-finding algorithms to identify
children with ASD from EMR and health claims databases.
2. Harmonize existing data on children and adolescents with ASD into an ASD registry database.
3. Conduct a web-based survey of parents of children affected by ASD to obtain information that is not available in health plan databases.
4. Obtain and store biosamples from registry participants and their family members for future studies
![Page 6: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/6.jpg)
Diagnostic Validation Process
• Records sampled based on:- Gender (M/F)- Age of Child (1-4, 5-11, 12-17)- Specialty of Provider (specialist/generalist)- Number of diagnoses (1 dx/2+ dx)
• ASD diagnoses are validated using structured record review followed by expert review
• Develop algorithm based on findings to assign reliability score to all ASD diagnoses in EMR
![Page 7: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/7.jpg)
Harmonize existing data
• Birth Certificates• Department of Developmental Services • Standardized assessments– ADOS (Autism Diagnostic Observation Scale)– CBCL (Child Behavior Checklist)– Mullen (cognitive measure)– Vineland (adaptive measure)
![Page 8: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/8.jpg)
Web-based Survey• What are the different treatment approaches used by children with
ASD? • What are the treatment burdens (financial, time) for families of
children with ASD?• What is the decision process used by families to select therapies for
their children?• What are parental perceptions of the efficacy of different treatments• To what extent do families access and use recommended treatments
for ASD and how is this related to perceptions of burden and efficacy?
![Page 9: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/9.jpg)
Survey Content• Diagnosis• Satisfaction with care• Services and treatments• Caregiver Strain Questionnaire• Pediatric Quality of Life Inventory (Peds QL)• The effect of child’s ASD on parent’s career• Demographics• Educational resources for family• Willingness to participate in future research• Saliva/Blood samples for future research
![Page 10: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/10.jpg)
Treatments and Services• Provided by a medical or other professional• Complementary and alternative medical (CAM)
treatments• Prescription medications• Vitamins/herbs/supplements• Provided at school• Provided at home
![Page 11: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/11.jpg)
Preliminary Results Prevalence
• 0-17 year olds• Data recorded in EMR from 1995-2010• Health plan members as of December 2010– Overall Prevalence: 1.2%
Total Children
Total ASD Cases
Site 1 Site 2 Site 3 Site 4 Site 5
2,049,442 23,811 1.5% 1.0% 1.6% 1.1% 0.86%
![Page 12: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/12.jpg)
Age Distribution: ASD Population
Age Site 1 Site 2 Site 3 Site 4 Site 5
0-4 7.26% 11.4% 10.1% 12.0% 9.95%
5-9 30.3% 34.3% 34.8% 35.6% 37.3%
10-14 40.7% 34.9% 37.1% 36.0% 35.9%
15-17 21.7% 19.3% 18.0% 16.4% 16.9%
![Page 13: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/13.jpg)
Sex Distribution: ASD Population
Sex Site 1 Site 2 Site 3 Site 4 Site 5
Male 82.1% 81.3% 78.8% 81.4% 83.6%
Female 17.9% 18.7% 21.2% 18.6% 16.4%
Overall male to female ratio: 4.29 (range: 3.71-5.11)
![Page 14: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/14.jpg)
Summary
• Large and diverse patient population• Extensive information in electronic medical records• Survey data• Genetic material• Ideal environment for studying variation in care,
comparing effectiveness and cost of treatments across practice environments, and studying dissemination of information and health policies related to autism
![Page 15: A Diverse Autism Registry for Etiologic and Effectiveness Studies Prevalance and Demographic Characteristics CROEN](https://reader034.vdocuments.mx/reader034/viewer/2022052621/557dd1ced8b42a124f8b4693/html5/thumbnails/15.jpg)
Acknowledgements• KPNC
– Lisa Croen– Vincent Yau– Marta Lutsky– Yinge Qian
• KPNW– Frances Lynch– Kathy Pearson
• KPSC– Karen Coleman– Virginia Quinn– Karen Schenk
• KPGA– Ashli Owen-Smith– Robert Davis– Janet Cummings
• Harvard Pilgrim– Jeanne Madden– Matthew Lakoma